---
title: "IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295708592.md"
description: "IDEXX Laboratories Inc. (IDXX) shares fell 2.74% to $570.58 on Wednesday, underperforming competitors like Johnson & Johnson and Medtronic during a mixed market session. This marked the stock's second consecutive day of losses, leaving it 25.90% below its 52-week high. Trading volume was notably lower than the 50-day average."
datetime: "2026-08-12T20:53:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295708592.md)
  - [en](https://longbridge.com/en/news/295708592.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295708592.md)
generator: "portal-rs"
---

# IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. (IDXX) slid 2.74% to $570.58 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.26% to 7,748.50 and the Dow Jones Industrial Average falling 0.04% to 53,770.27.

This was the stock's second consecutive day of losses.

IDEXX Laboratories Inc. closed 25.90% short of its 52-week high of $769.98, which the company achieved on November 26th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.41% to $260.86, Medtronic PLC (MDT) rose 0.09% to $90.76, and Boston Scientific Corp. (BSX) rose 0.45% to $51.42.

Trading volume (404,497) remained 259,051 below its 50-day average volume of 663,548.

Data source: Dow Jones Market Data, FactSet. Data compiled August 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-12-26 1653ET

### Related Stocks

- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)

## Related News & Research

- [Baird Financial Group Inc. Sells 6,500 Shares of IDEXX Laboratories, Inc. $IDXX](https://longbridge.com/en/news/298551472.md)
- [IDEXX Laboratories, Inc. $IDXX Shares Sold by Allworth Financial LP](https://longbridge.com/en/news/298823925.md)
- [IDXX: Innovation-driven growth and rising diagnostic utilization fuel robust financial and margin outlook](https://longbridge.com/en/news/298943864.md)
- [IDEXX director Lawrence D. Kingsley disposes of 2,203 common shares for $1.17 million](https://longbridge.com/en/news/298504313.md)
- [Azimuth Capital Investment Management LLC Sells 12,103 Shares of IDEXX Laboratories, Inc. $IDXX](https://longbridge.com/en/news/298125911.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**